However, in the patient described in this report, dystrophinopathies, such as DMD and BMD, were ruled out because the expression of sarcolemmal dystrophin was diffusely present and molecular tests for dystrophin gene were normal. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.